Inspire Medical Systems, Inc. Earnings Per Share, Basic and Diluted
Inspire Medical Systems, Inc. (INSP) reported Earnings Per Share, Basic and Diluted of -$0.60 per share for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-04.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2021-05-04
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.60.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for the quarter ending 2020-12-31 was -$0.28.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for the quarter ending 2020-09-30 was -$0.39.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for the quarter ending 2020-06-30 was -$0.88.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for fiscal 2020 was -$2.19.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for fiscal 2019 was -$1.40.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for fiscal 2018 was -$1.50.
- Inspire Medical Systems, Inc. earnings per share, basic and diluted for fiscal 2017 was -$14.88.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-03-31 | -$0.60 10-Q · filed 2021-05-04 | -$0.88 derived: net income ÷ weighted average shares · filed 2022-11-01 | -$1.26 derived: net income ÷ weighted average shares · filed 2022-11-01 | -$2.13 derived: net income ÷ weighted average shares · filed 2022-11-01 |
| 2020-12-31 | -$0.28 10-K · filed 2021-02-24 | -$0.66 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$1.53 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$2.19 10-K · filed 2021-02-24 |
| 2020-09-30 | -$0.39 10-K · filed 2021-02-24 | -$1.26 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$1.93 10-Q · filed 2020-11-02 | -$2.32 derived: net income ÷ weighted average shares · filed 2021-11-02 |
| 2020-06-30 | -$0.88 10-K · filed 2021-02-24 | -$1.56 10-Q · filed 2020-08-04 | -$1.95 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$2.30 derived: net income ÷ weighted average shares · filed 2021-11-02 |
| 2020-03-31 | -$0.67 10-Q · filed 2021-05-04 | -$1.05 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$1.40 derived: net income ÷ weighted average shares · filed 2021-11-02 | -$1.72 derived: net income ÷ weighted average shares · filed 2021-11-02 |
| 2019-12-31 | -$0.38 10-K · filed 2021-02-24 | -$0.72 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.04 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.40 10-K · filed 2021-02-24 |
| 2019-09-30 | -$0.34 10-K · filed 2021-02-24 | -$0.67 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.02 10-Q · filed 2020-11-02 | -$1.24 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-06-30 | -$0.32 10-K · filed 2021-02-24 | -$0.67 10-Q · filed 2020-08-04 | -$0.90 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.12 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2019-03-31 | -$0.35 10-K · filed 2021-02-24 | -$0.58 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$0.80 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.18 derived: net income ÷ weighted average shares · filed 2021-02-24 |
| 2018-12-31 | -$0.22 10-K · filed 2020-02-25 | -$0.44 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$0.81 derived: net income ÷ weighted average shares · filed 2021-02-24 | -$1.50 10-K · filed 2021-02-24 |
| 2018-09-30 | -$0.22 10-K · filed 2020-02-25 | -$0.60 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$1.40 10-Q · filed 2019-11-05 | -$2.28 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-06-30 | -$0.43 10-K · filed 2020-02-25 | -$1.66 10-Q · filed 2019-08-06 | -$3.10 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$4.79 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2018-03-31 | -$5.05 10-K · filed 2020-02-25 | -$8.54 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$12.00 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$16.13 derived: net income ÷ weighted average shares · filed 2020-02-25 |
| 2017-12-31 | -$3.46 10-K · filed 2019-02-26 | -$6.87 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$10.99 derived: net income ÷ weighted average shares · filed 2020-02-25 | -$14.88 10-K · filed 2020-02-25 |
| 2017-09-30 | -$3.42 10-K · filed 2019-02-26 | -$7.55 derived: net income ÷ weighted average shares · filed 2019-02-26 | -$11.45 10-Q · filed 2018-11-06 | |
| 2017-06-30 | -$4.14 10-K · filed 2019-02-26 | -$8.04 10-Q · filed 2018-08-07 | ||
| 2017-03-31 | -$3.90 10-K · filed 2019-02-26 | |||
| 2016-12-31 | -$16.90 10-K · filed 2019-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |